Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $81.1700 (-0.51%) ($80.3200 - $81.6300) on Thu. May. 23, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.01% (three month average) | RSI | 63 | Latest Price | $81.1700(-0.51%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV advances 0.4% a day on average for past five trading days. | Weekly Trend | ABBV advances 1.5% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(60%) DIA(50%) VYM(50%) IVE(49%) SPLV(49%) | Factors Impacting ABBV price | ABBV will decline at least -0.505% in a week (0% probabilities). VXX(-15%) TLT(-15%) IFRA(-11%) VIXM(-10%) IGOV(-4%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.505% (StdDev 1.01%) | Hourly BBV | 0 () | Intraday Trend | 1% | | | |
|
5 Day Moving Average | $80.58(0.73%) | 10 Day Moving Average | $79.48(2.13%) | 20 Day Moving Average | $79.14(2.57%) | To recent high | -3.3% | To recent low | 5.6% | Market Cap | $143.207b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |